Are you looking for an exciting PhD opportunity with industry focus? Join the ARC Industrial Transformation Training Centre for Cryo-electron Microscopy of Membrane Proteins (CCeMMP)!
Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
ASCEPT was founded in 1966, and held its first scientific meeting a year later. Since that time, ASCEPT has developed into the peak professional society devoted to advancing excellence in Clinical and Experimental Pharmacology and Toxicology in Australasia.
THINKING OF JOINING?
We promote advances in research, provide teaching & training and ensure that ASCEPT has a major role in advising government and other organisations on related matters. You can also benefit from discounted rates and networking opportunities.
ASCEPT-APSA 2020 Joint Scientific Meeting
24 – 26 November 2020
SPECIAL INTEREST GROUPS
ASCEPT members have many diverse interests and so have formed Special Interest Groups to acknowledge these strengths, to enhance the cohesion of the Society and to promote and advance the study and application of pharmacology and toxicology in its broadest context.
ASCEPT recent articles and events
November 5th - 6th
Abstract submission by 23rd October
Symposium will include selected student talks
(10 min) and a careers panel discussion
Continuing the successful series of “Advances in Urogenital Research”, held since 2004 join us for our annual symposium, which this...
The Executive has created a new special interest group forum for discussions on COVID-19. Members can now request access.
The organising committee of the 14th meeting of the Asia Pacific Federation of Pharmacologists have this week announced the change of date...
It is with great sadness the ASCEPT Executive notify you that Professor Sir Alasdair Breckenridge passed away on 13 December...
Dr. Stefanie Hennig joined Certara Strategic Consulting as an Associate Director of Consulting Service in July 2019. She will be working as a consultant in PK and PK/PD modelling and simulation in various phases of drug development in a variety of population groups.
The Academy has elected 40 new Fellows, including 19 women, and will discuss the global pandemic threat at its annual meeting. The Australian Academy of Health and Medical Sciences has elected 40 new Fellows...
Leading cardiovascular disease researcher Professor Rebecca Ritchie has been appointed as the new Theme Leader of the Drug Discovery Biology Theme in the Monash Institute of Pharmaceutical Sciences (MIPS). Professor Ritchie is currently an NHMRC Senior Research Fellow and Head of the Heart Failure Laboratory at the Baker Heart and Diabetes Institute.
Professor Jason Roberts from the UQ School of Pharmacy has been recognised as one of the country's leading researchers. The Australian’s 2019 Research magazine has named Professor Roberts as Australia’s Leading Researcher in both Communicable Diseases and Critical Care.
Real-time decision making equals empowered students. That is the essence of SimPHARM™, a state-of-the-art simulation tool developed at the University of Otago and now commercially licensed by a United States-based company to help pharmacy students learn via a realistic clinical experience.
ASCEPT-PAGANZ 2019 Joint Scientific Meeting
Rydges Lakeland Resort, Queenstown, New Zealand
25 – 29 November 2019
Call for abstracts + registration opens
Monday 15 April
Abstract submission deadline
Monday 9 September
Early bird registration deadline + accommodation booking deadline
Monday 21 October
Special interest groups
Supporting Member Collaboration
ASCEPT members have many diverse interests and so have formed Special Interest Groups to acknowledge these strengths, to enhance the cohesion of the Society and to promote and advance the study and application of pharmacology and toxicology in its broadest context. Currently, there are SIGs in the following areas.